Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-20

Clinical Trial Update: Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) [Phase 2]

View source ↗

Summary

Phase 2 trial of ChimeriVax-JE and STAMARIL vaccines completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ChimeriVax-JE (live attenuated Japanese encephalitis vaccine)
  • Stamaril (Yellow fever vaccine (live attenuated))

Snippet

Sponsor: Sanofi | Conditions: Japanese Encephalitis, Yellow Fever | Phase 2 | Status: COMPLETED | Results posted: 2012-09-20